Get a deeper insight into the potential performance of AbbVie (ABBV) for the quarter ended March 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some ...

Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that ...

Starting in 2026, Medicare Part D will exclude several high-cost and lifestyle-related drugs, including Humira, Wegovy, and ...

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

Market volatility in 2026 has reminded investors that earned income alone is fragile. When tariff fears rattle equities and ...

From health disinformation to Rare Disease Week to National Prescription Take Back Day, here are the top health stories for ...

Medicare Part D will see major changes in 2026, including a $2,100 annual cap on out-of-pocket spending for covered drugs and negotiated price cuts on 10 high-cost medications. Some prescriptions, ...

Fifteen-year-old Kylar of Chambersburg will celebrate his birthday on May 11th while bravely facing a rare genetic disorder ...